Santhera Announces First Half-Year 2021 Financial Results and Updates on Corporate Progress
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Eva Kalias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, October 1, 2021: SIX Exchange Regulation has permitted Santhera to publish its interim report for the six-month period ended June 30
Santhera Pharmaceuticals Holding AG: Santhera Publishes Agenda for its Annual General Meeting the invitation to its Annual General Meeting (AGM) , at 10:30 . Invitation and agenda items for the AGM The invitation and agenda items for the Annual General Meeting can be viewed on Santhera's website at https://www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings. Selected agenda items: increases As previously announced, the Board of Directors (BoD) proposes various capital increases to Santhera's shareholders at the forthcoming AGM. These should give the Company su...
is starting today on the SIX Swiss Exchange. On May 4, 2021, Santhera Pharmaceuticals Holding AG issued Senior Unsecured Convertible Bonds due 2024 (the 2021/24 Bonds) in the aggregate principal amount of CHF 30,270,375. The 2021/24 Bonds have been admitted to trading on the SIX Swiss Exchange. The first trading day is today, May 7, 2021. The ticker symbol of the 2021/24 Bonds is SAN21 and ISIN CH0563348744. As set out in the terms and conditions [1], the conversion period during which a bondholder may exercise the conversion rights for the 2021/24 Bonds has started on May 4, 2021, and...
Santhera Pharmaceuticals Holding AG: Santhera gibt den ersten Handelstag der neuen Wandelanleihe an der SIX Swiss Exchange bekannt Pratteln, Schweiz, vorrangigen 375 mit Fälligkeit 2024 heute an der SIX Swiss Exchange beginnt. Am 4. Mai 2021 hat die Santhera Pharmaceuticals Holding AG eine vorrangige ungesicherte Wandelanleihe mit Fälligkeit 2024 (die Anleihe 2021/24) im Gesamtnennbetrag von CHF 30'270 '375 ausgegeben. Die Anleihe 2021/24 wurde zum Handel an der SIX Swiss Exchange zugelassen. Der erste Handelstag ist heute, der 7. Mai 2021. Das Tickersymbol der Anleihe 2021/24 lautet SAN...